Contracts › FA237725CB005
FA237725CB005: Act-Iv Ongoing Development, Integration, Experimentation, and Validation for Enhanced Lethality
Awarded to Northrop Grumman Systems Corporation by Department of the Air Force.
$2.2Mobligated
$4.6Mpotential value
05 September 2027current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | FA237725CB005 |
|---|---|
| Awardee | Northrop Grumman Systems Corporation |
| Awarding agency | Department of the Air Force |
| Awarding office | FA2377 USAF AFMC AFRL PZL AFRL RYKS |
| NAICS | 541715 Research and Development in the Physical, Engineering, and Life Sciences (Except Nanotechnology and Biotechnology) |
| PSC | AC12 National Defense R&D Services; Department of Defense - Military; Applied Research |
| Place of performance | MD |
| Offers received | 1 |
| Period of performance | 05 September 2025 to 05 September 2027 |
| Potential end | 05 September 2027 |
| Estimated recompete solicitation | ~Q1 2027 (estimate, ~6 months before expiry) |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 03 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 541715 contracts · All expiring contracts · USASpending record